Chemplast Sanmar (CHEMPLASTS) Q1 26/27 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 26/27 earnings summary
2 Sep, 2026Executive summary
Q1 FY27 consolidated revenue was INR 1,125 crore, up 2% year-over-year but down from the previous quarter, amid a volatile global environment and geopolitical events impacting raw material availability and demand.
EBITDA turned negative at INR 115 crore, down from a profit in the prior year and quarter, due to sharp input cost increases and exceptional charges.
Net loss after tax was INR 176 crore, compared to a loss of INR 64 crore in Q1 FY26 and INR 45 crore in Q4 FY26.
Demand for Paste PVC recovered in June as Middle East supply issues eased, and downstream operating rates improved to 70%-80%.
Regulatory changes, including customs duty and anti-dumping measures, influenced competitive dynamics and market conditions.
Financial highlights
Consolidated revenue was INR 1,125 crore, up 2% YoY but down 10% QoQ; standalone revenues from operations were INR 596 crore.
EBITDA was a loss of INR 115 crore, with an exceptional charge of INR 149.92 crore for onerous contracts and inventory writedown.
Net debt stood at INR 1,419 crore at quarter end.
Specialty chemical segment revenue was INR 427 crore, up 31% YoY in volumes; Value Added Chemicals revenue was INR 179 crore.
PAT was a loss of INR 176 crore, compared to a loss of INR 64 crore YoY and INR 45 crore QoQ.
Outlook and guidance
Management expects continued demand recovery in Paste PVC, supported by customs duty reinstatement and improved supply.
CMCD is on track for INR 1,000 crore revenue target, with strong order book and new product/geographic expansion.
Full ramp-up of R32 refrigerant gas capacity expected by fiscal year-end, with both domestic and international sales planned.
Management anticipates a turnaround in profitability from Q3 as high-cost inventory is consumed and spreads normalize.
Ongoing investments in capacity expansion and new product development to drive future growth.
Latest events from Chemplast Sanmar
- Record pre-exceptional PBT rose 7% as Cuddalore margins and lower costs lifted results.CHEMPLASTS
Q4 17/18 - Chloromethanes margins lifted FY19 PBT as a major scheme reshaped the business.CHEMPLASTS
Q4 18/19 - EBITDA margin rose to 30.7%; consolidated profit included major investment-redemption gains.CHEMPLASTS
Q4 20/21 - Higher depreciation, finance costs and COVID-19 pressure drove a sharp FY20 profit decline.CHEMPLASTS
Q4 19/20 - Record FY22 performance and IPO-led deleveraging fund the next capacity-growth phase.CHEMPLASTS
Q4 21/22 - Price and energy pressure cut FY23 earnings as major growth projects advanced.CHEMPLASTS
Q4 22/23 - Q1 FY25 saw strong revenue and profit growth, led by specialty chemicals and CMC expansion.CHEMPLASTS
Q1 24/25 - FY25 revenue and EBITDA surged, led by specialty chemicals; net loss narrowed despite PVC headwinds.CHEMPLASTS
Q4 24/25 - Q1 FY26 saw a 4% YoY revenue drop, net loss, and one-time tax and revaluation impacts.CHEMPLASTS
Q1 25/26